//
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
Sox17 Controls Emergence and Remodeling of Nestin-Expressing Coronary Vessels
Long-term effects of intensive glucose lowering on cardiovascular outcomes
2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines
Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients
Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation